Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magali Terme

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Clinical & Developmental Immunology|January 16, 2013
Modulation of immunity by antiangiogenic molecules in cancerMagali Terme, Orianne Colussi, Elie Marcheteau, et al.
Clinics and Research in Hepatology and Gastroenterology|August 13, 2013
Immunity and squamous cell carcinoma of the anus: epidemiological, clinical and therapeutic aspectsSimon Pernot, Magali Terme, Aziz Zaanan, et al.
Bulletin Du Cancer|November 12, 2003
[NK cell-based immunotherapy: new prospects and involvement of dendritic cells]Christophe Borg, Julien Taieb, Magali Terme, et al.
World Journal of Gastroenterology|May 17, 2014
Colorectal cancer and immunity: what we know and perspectivesSimon Pernot, Magali Terme, Thibault Voron, et al.
Frontiers in Oncology|April 26, 2014
Control of the immune response by pro-angiogenic factorsThibault Voron, Elie Marcheteau, Simon Pernot, et al.
Cytokine & Growth Factor Reviews|December 25, 2007
Dendritic cells and innate defense against tumor cellsEvelyn Ullrich, Cédric Ménard, Caroline Flament, et al.
Oncoimmunology|July 30, 2013
Immunotherapy of HPV-associated head and neck cancer: Critical parametersMevyn Nizard, Federico Sandoval, Cecile Badoual, et al.
Cancer Research|October 31, 2012
VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancerMagali Terme, Simon Pernot, Elie Marcheteau, et al.
Oncoimmunology|August 15, 2022
Synergistic effect of combining sunitinib with a peptide-based vaccine in cancer treatment after microenvironment remodelingAlice Mougel, Fanny Méjean, Thi Tran, et al.
Cancer Research|August 15, 2009
The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cellsMagali Terme, Grégoire Mignot, Evelyn Ullrich, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Clinical & Developmental Immunology|January 16, 2013
Modulation of immunity by antiangiogenic molecules in cancerMagali Terme, Orianne Colussi, Elie Marcheteau, et al.
Clinics and Research in Hepatology and Gastroenterology|August 13, 2013
Immunity and squamous cell carcinoma of the anus: epidemiological, clinical and therapeutic aspectsSimon Pernot, Magali Terme, Aziz Zaanan, et al.
Bulletin Du Cancer|November 12, 2003
[NK cell-based immunotherapy: new prospects and involvement of dendritic cells]Christophe Borg, Julien Taieb, Magali Terme, et al.
World Journal of Gastroenterology|May 17, 2014
Colorectal cancer and immunity: what we know and perspectivesSimon Pernot, Magali Terme, Thibault Voron, et al.
Frontiers in Oncology|April 26, 2014
Control of the immune response by pro-angiogenic factorsThibault Voron, Elie Marcheteau, Simon Pernot, et al.
Cytokine & Growth Factor Reviews|December 25, 2007
Dendritic cells and innate defense against tumor cellsEvelyn Ullrich, Cédric Ménard, Caroline Flament, et al.
Oncoimmunology|July 30, 2013
Immunotherapy of HPV-associated head and neck cancer: Critical parametersMevyn Nizard, Federico Sandoval, Cecile Badoual, et al.
Cancer Research|October 31, 2012
VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancerMagali Terme, Simon Pernot, Elie Marcheteau, et al.
Oncoimmunology|August 15, 2022
Synergistic effect of combining sunitinib with a peptide-based vaccine in cancer treatment after microenvironment remodelingAlice Mougel, Fanny Méjean, Thi Tran, et al.
Cancer Research|August 15, 2009
The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cellsMagali Terme, Grégoire Mignot, Evelyn Ullrich, et al.
Pageof 5